Delivery Order SPE2DB22D1106-SPE2DB25FEDV1
Award Date
3/19/25
Potential Completion Date
3/20/25
Potential Value
$3.9K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $3,759.96, is for the delivery of Ozempic 0.25-0.5 mg/dose pens with a completion date of January 24, 2025. The contract is a Firm Fixed Price Delivery Order with no set-aside designation, indicating open competition. AmerisourceBergen holds a larger Indefinite Delivery Contract (IDC) with the DLA...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,555.43, is for the delivery of Ozempic 0.25-0.5 mg/dose pens with a performance period through December 9, 2024. The contract is a Firm Fixed Price Delivery Order, with no set-aside designation. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $3,294.61, is for the delivery of Ozempic 0.25-0.5 mg/dose pens with a completion date of November 20, 2024. The contract is a Firm Fixed Price Delivery Order with no set-aside designation, indicating open competition. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $30,011.90, is for the delivery of Ozempic 0.25-0.5 mg/dose pens with a 3 ml volume. This is a firm fixed-price delivery order contract that runs through January 13, 2025. The contract is not designated as a set-aside. AmerisourceBergen holds a larger Indefinite Delivery Contract (IDC) with the DLA...
This is a federal contract award to AmerisourceBergen Drug Corporation, a major pharmaceutical distributor and healthcare solutions provider, for the supply of Ozempic 0.25-0.5 mg/dose pens (3 ml). The contract, valued at $3,006.54, is a delivery order awarded by the Defense Logistics Agency (DLA), a defense agency. The contract is a firm fixed-price arrangement with a period of performance ending on March 10, 2025. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $42,470.89, is for the delivery of Ozempic 0.25-0.5 mg/dose pens with a 3 mL capacity. The contract is a Firm Fixed Price Delivery Order with a period of performance through January 29, 2025. The contract is not designated as a set-aside. AmerisourceBergen holds a $999,999,999 Indefinite Delivery...
This is a federal contract award to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $16,959.56, is a delivery order issued by the Defense Logistics Agency (DLA) for the supply of Ozempic 0.25-0.5 mg/dose pens. The contract is a firm-fixed-price arrangement with a completion date of June 28, 2024. The contract does not have a set-aside designation, indicating open competition. AmerisourceBergen holds a significant...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract award, valued at $10,333.55, is for the delivery of Ozempic 0.25-0.5 mg/dose pens with a 3 mL capacity. The contract is a Firm Fixed Price Delivery Order with a completion date of May 31, 2024. The contract is not designated with any set-aside requirements, indicating open competition. AmerisourceBergen holds a...
This is a federal contract award from the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $11,182.15, is for the delivery of Ozempic 0.25-0.5 mg/dose pens with a completion date of March 28, 2025. The contract is a delivery order under an Indefinite Delivery Contract (IDC) valued at $999,999,999 that AmerisourceBergen holds with the DLA Troop Support Medical, which...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $2,246.37, is for the delivery of Ozempic 0.25-0.5 mg/dose pens. It is a firm fixed price delivery order contract with a completion date of March 12, 2025. The contract is not designated as a set-aside. AmerisourceBergen holds a larger $999,999,999 Indefinite Delivery Contract (IDC) with the DLA...